449 related articles for article (PubMed ID: 32888318)
1. Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control.
Vincent SJ; Tan Q; Ng ALK; Cheng GPM; Woo VCP; Cho P
Ophthalmic Physiol Opt; 2020 Nov; 40(6):728-737. PubMed ID: 32888318
[TBL] [Abstract][Full Text] [Related]
2. One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial.
Tan Q; Ng AL; Choy BN; Cheng GP; Woo VC; Cho P
Ophthalmic Physiol Opt; 2020 Sep; 40(5):557-566. PubMed ID: 32776533
[TBL] [Abstract][Full Text] [Related]
3. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results.
Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kakehashi A
Jpn J Ophthalmol; 2018 Sep; 62(5):544-553. PubMed ID: 29974278
[TBL] [Abstract][Full Text] [Related]
4. Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial.
Tan Q; Ng AL; Cheng GP; Woo VC; Cho P
Cont Lens Anterior Eye; 2023 Feb; 46(1):101723. PubMed ID: 35654683
[TBL] [Abstract][Full Text] [Related]
5. Repeatability of pupil size measurements with NIDEK OPD-Scan III in myopic children.
Tan Q; Ng AL; Cheng GP; Woo VC; Cho P
Ophthalmic Physiol Opt; 2021 Mar; 41(2):431-436. PubMed ID: 33294971
[TBL] [Abstract][Full Text] [Related]
6. Retinal image quality in myopic children undergoing orthokeratology alone or combined with 0.01% atropine.
Tan Q; Cho P; Ng ALK; Cheng GPM; Woo VCP; Vincent SJ
Eye Vis (Lond); 2023 Jun; 10(1):21. PubMed ID: 37259133
[TBL] [Abstract][Full Text] [Related]
7. Combined Atropine with Orthokeratology for Myopia Control: Study Design and Preliminary Results.
Tan Q; Ng AL; Cheng GP; Woo VC; Cho P
Curr Eye Res; 2019 Jun; 44(6):671-678. PubMed ID: 30632410
[No Abstract] [Full Text] [Related]
8. The effects of entrance pupil centration and coma aberrations on myopic progression following orthokeratology.
Santodomingo-Rubido J; Villa-Collar C; Gilmartin B; Gutiérrez-Ortega R; Suzaki A
Clin Exp Optom; 2015 Nov; 98(6):534-40. PubMed ID: 26283026
[TBL] [Abstract][Full Text] [Related]
9. The influence of orthokeratology compression factor on ocular higher-order aberrations.
Lau JK; Vincent SJ; Cheung SW; Cho P
Clin Exp Optom; 2020 Jan; 103(1):123-128. PubMed ID: 31264269
[TBL] [Abstract][Full Text] [Related]
10. Impact of pupil diameter on axial growth in orthokeratology.
Chen Z; Niu L; Xue F; Qu X; Zhou Z; Zhou X; Chu R
Optom Vis Sci; 2012 Nov; 89(11):1636-40. PubMed ID: 23026791
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis.
Wang Z; Wang P; Jiang B; Meng Y; Qie S; Yan Z
PLoS One; 2023; 18(7):e0282286. PubMed ID: 37494360
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the long-term effects of atropine in combination with Orthokeratology and defocus incorporated multiple segment lenses for myopia control in Chinese children and adolescents.
Tang T; Lu Y; Li X; Zhao H; Wang K; Li Y; Zhao M
Eye (Lond); 2024 Jun; 38(9):1660-1667. PubMed ID: 38418604
[TBL] [Abstract][Full Text] [Related]
13. The effect of orthokeratology on axial length elongation in children with myopia: Contralateral comparison study.
Na M; Yoo A
Jpn J Ophthalmol; 2018 May; 62(3):327-334. PubMed ID: 29524061
[TBL] [Abstract][Full Text] [Related]
14. Higher-Order Aberrations and Axial Elongation in Myopic Children Treated With Orthokeratology.
Lau JK; Vincent SJ; Cheung SW; Cho P
Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):22. PubMed ID: 32068792
[TBL] [Abstract][Full Text] [Related]
15. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
[TBL] [Abstract][Full Text] [Related]
16. Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial.
Yu S; Du L; Ji N; Li B; Pang X; Li X; Ma N; Huang C; Fu A
BMC Ophthalmol; 2022 Nov; 22(1):438. PubMed ID: 36380280
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive effect of orthokeratology and low dose atropine on axial elongation in fast-progressing myopic children-A preliminary retrospective study.
Chen Z; Huang S; Zhou J; Xiaomei Q; Zhou X; Xue F
Cont Lens Anterior Eye; 2019 Aug; 42(4):439-442. PubMed ID: 30482510
[TBL] [Abstract][Full Text] [Related]
18. Effect of COVID-19 home confinement on the efficacy of orthokeratology, 0.01% atropine and combined treatment.
Xu S; Jiang J; Yu M; Gao J; Wang M; Kuang L; Hu Y; Kee CS; Yang X; He M
Acta Ophthalmol; 2024 Jun; 102(4):e620-e627. PubMed ID: 37983888
[TBL] [Abstract][Full Text] [Related]
19. Short- and Long-Term Changes in Corneal Aberrations and Axial Length Induced by Orthokeratology in Children Are Not Correlated.
Santodomingo-Rubido J; Villa-Collar C; Gilmartin B; Gutiérrez-Ortega R; Suzaki A
Eye Contact Lens; 2017 Nov; 43(6):358-363. PubMed ID: 27341092
[TBL] [Abstract][Full Text] [Related]
20. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression.
Fu A; Stapleton F; Wei L; Wang W; Zhao B; Watt K; Ji N; Lyu Y
Br J Ophthalmol; 2020 Nov; 104(11):1535-1541. PubMed ID: 32086237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
